DIA
CLVS

Denver Investment Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Denver Investment Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-35,694
Closed -$2.65M – 629
2015
Q1 		$2.65M Buy
35,694
+1,610
+5% +$114K 0.09% 235
2014
Q4 		$1.91M Buy
34,084
+512
+2% +$26.9K 0.06% 281
2014
Q3 		$1.52M Sell
33,572
-277
-0.8% -$11.6K 0.05% 306
2014
Q2 		$1.4M Sell
33,849
-55,503
-62% -$2.86M 0.04% 331
2014
Q1 		$6.19M Buy
89,352
+47,829
+115% +$3.51M 0.18% 161
2013
Q4 		$2.5K Buy
41,523
+8,491
+26% +$462K 0.07% 285
2013
Q3 		$2.01M Buy
+33,032
New +$2.34M 0.04% 346

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Denver Investment Advisors's CLVS Position: Q2 2015 in Review

Denver Investment Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q2 2015, closing a stake of 35,694 shares — an estimated $2.65M sold.

Denver Investment Advisors first reported a position in CLVS in Q3 2013 and held it in 7 quarters. The position peaked at $6.19M in Q1 2014. 176 funds tracked by Wall St. Rank hold CLVS as of Q2 2015.

  • Denver Investment Advisors reported no remaining Clovis Oncology, Inc. position as of Q2 2015 after selling out during the quarter.
  • Denver Investment Advisors sold 35,694 Clovis Oncology, Inc. shares in Q2 2015, an estimated $2.65M.
  • Denver Investment Advisors first reported a position in Clovis Oncology, Inc. in Q3 2013 and held it in 7 quarters.
  • Denver Investment Advisors's Clovis Oncology, Inc. position peaked at $6.19M in Q1 2014.
  • 176 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2015.

Based on Denver Investment Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.